Capital Biosciences
Capital Biosciences is a biotechnology company specializing in cell biology, viral systems, and human biospecimens, offering products and custom services for cell immortalization, gene expression, and translational research.
Overview
Capital Biosciences is a U.S.-based biotechnology company founded around 2006–2007, focused on providing cell biology tools, viral systems, and human biospecimens for research and drug discovery. The company offers a wide range of products including cell immortalization systems, recombinant viral vectors, cDNA clones, purified proteins, and clinically defined human tissues, supporting both basic and translational research. A key strength of Capital Biosciences is its integration of biospecimen sourcing with molecular and cellular tools, enabling researchers to move from patient-derived samples to functional studies. In addition to catalog products, the company provides custom services such as recombinant virus production, stable cell line generation, and protein quantification, positioning itself as a flexible partner for academic, pharmaceutical, and biotech organizations. The company is located in Maryland’s biotech corridor and serves global clients in life science research and drug development.
Key techniques
Capital Biosciences supports advanced cellular and molecular biology workflows.
Product lines
Capital Biosciences offers a hybrid portfolio of biological materials and custom services.
Cells ›
Adeno-Associated Viruses (AAVs) ›
Capabilities
Capital Biosciences integrates biospecimen sourcing with molecular and cellular engineering
QC & documentation
Capital Biosciences provides documentation to support reliable research outcomes
Lead time & shipping
Timelines vary depending on product type and customization